Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers

Florence Coussy(Inserm), Ivan Bièche(Centre National de la Recherche Scientifique)
Journal of Hematology & Oncology
February 22, 2020
Cited by 54


Related Papers